XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.23.2

Restatement of Prior Financial Information (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Accounting Changes and Error Corrections [Abstract] |
Schedule of Error Corrections and Prior Period Adjustments |
|  | March 31, 2023 |  | Adjustments |  | March 31, 2023
|  | As previously reported |  |  | As restated
CONSOLIDATED BALANCE SHEETS
Receivables, net |  | $ | 79,003 |  |  | $ | (2,998) |  |  | $ | 76,005 |
Income taxes receivable |  | $ | 9 |  |  | $ | (9) |  |  | $ | — |
Total current assets |  | $ | 457,688 |  |  | $ | (3,007) |  |  | $ | 454,681 |
Goodwill |  | $ | 276,028 |  |  | $ | (6,622) |  |  | $ | 269,406 |
Income taxes receivable, non-current |  | $ | — |  |  | $ | 15,943 |  |  | $ | 15,943 |
Total non-current assets |  | $ | 534,940 |  |  | $ | 9,321 |  |  | $ | 544,261 |
Total assets |  | $ | 992,628 |  |  | $ | 6,314 |  |  | $ | 998,942 |
Medical liabilities |  | $ | 101,394 |  |  | $ | (2,998) |  |  | $ | 98,396 |
Income taxes payable |  | $ | — |  |  | $ | 11,289 |  |  | $ | 11,289 |
Total current liabilities |  | $ | 164,954 |  |  | $ | 8,291 |  |  | $ | 173,245 |
Deferred tax liability |  | $ | 3,695 |  |  | $ | 10,668 |  |  | $ | 14,363 |
Total non-current liabilities |  | $ | 249,745 |  |  | $ | 10,668 |  |  | $ | 260,413 |
Total liabilities |  | $ | 414,699 |  |  | $ | 18,959 |  |  | $ | 433,658 |
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation ("APC") |  | $ | 14,729 |  |  | $ | (452) |  |  | $ | 14,277 |
Retained earnings |  | $ | 207,300 |  |  | $ | (11,751) |  |  | $ | 195,549 |
Non-controlling interest |  | $ | 3,156 |  |  | $ | (442) |  |  | $ | 2,714 |
Total stockholders’ equity |  | $ | 563,200 |  |  | $ | (12,193) |  |  | $ | 551,007 |
|  | Three months ended March 31, 2023 |  | Adjustments |  | Three months ended March 31, 2023 |  |
|  | As previously reported |  |  | As restated |
CONSOLIDATED STATEMENTS OF INCOME |  |
Provision for income taxes |  | $ | 5,102 |  |  | $ | 1,819 |  |  | $ | 6,921 |  |  |
Net income |  | $ | 14,307 |  |  | $ | (1,819) |  |  | $ | 12,488 |  |  |
Net income attributable to noncontrolling interests |  | $ | (315) |  |  | $ | (329) |  |  | $ | (644) |  |  |
Net income attributable to Apollo Medical Holdings, Inc. |  | $ | 14,622 |  |  | $ | (1,490) |  |  | $ | 13,132 |  |  |
Earnings per share – basic |  | $ | 0.31 |  |  | $ | (0.03) |  |  | $ | 0.28 |  |  |
Earnings per share – diluted |  | $ | 0.31 |  |  | $ | (0.03) |  |  | $ | 0.28 |  |  |
|  | March 31, 2023 |  | Adjustments |  | March 31, 2023 |  |
|  | As previously reported |  |  | As restated |
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY |  |
Mezzanine Equity – Non-controlling Interest in APC - Net loss |  | $ | (1,400) |  |  | $ | (329) |  |  | $ | (1,729) |  |  |
Retained Earnings (Accumulated Deficit) - Net income |  | $ | 14,622 |  |  | $ | (1,490) |  |  | $ | 13,132 |  |  |
Mezzanine Equity – Non-controlling Interest in APC |  | $ | 14,729 |  |  | $ | (452) |  |  | $ | 14,277 |  |  |
Retained Earnings (Accumulated Deficit) |  | $ | 207,300 |  |  | $ | (11,751) |  |  | $ | 195,549 |  |  |
Non-controlling interest |  | $ | 3,156 |  |  | $ | (442) |  |  | $ | 2,714 |  |  |
Stockholders’ Equity |  | $ | 563,200 |  |  | $ | (12,193) |  |  | $ | 551,007 |  |  |
|  | Three months ended March 31, 2023 |  | Adjustments |  | Three months ended March 31, 2023 |  |
|  | As previously reported |  |  | As restated |
CONSOLIDATED STATEMENTS OF CASH FLOWS |  |
Net income |  | $ | 14,307 |  |  | $ | (1,819) |  |  | $ | 12,488 |  |  |
Deferred tax |  | $ | 790 |  |  | $ | (507) |  |  | $ | 283 |  |  |
Income taxes payable/receivable |  | $ | 4,007 |  |  | $ | 2,326 |  |  | $ | 6,333 |  |  |
|  | December 31, 2022 |  | Adjustments |  | December 31, 2022
|  | As previously reported |  |  | As restated
CONSOLIDATED BALANCE SHEETS
Receivables, net |  | $ | 52,629 |  |  | $ | (2,998) |  |  | $ | 49,631 |
Income taxes receivable |  | $ | 4,015 |  |  | $ | (4,015) |  |  | $ | — |
Total current assets |  | $ | 435,138 |  |  | $ | (7,013) |  |  | $ | 428,125 |
Goodwill |  | $ | 275,675 |  |  | $ | (6,622) |  |  | $ | 269,053 |
Income taxes receivable, non-current |  | $ | — |  |  | $ | 15,943 |  |  | $ | 15,943 |
Total non-current assets |  | $ | 528,767 |  |  | $ | 9,321 |  |  | $ | 538,088 |
Total assets |  | $ | 963,905 |  |  | $ | 2,308 |  |  | $ | 966,213 |
Medical liabilities |  | $ | 84,253 |  |  | $ | (2,998) |  |  | $ | 81,255 |
Income taxes payable |  | $ | — |  |  | $ | 4,279 |  |  | $ | 4,279 |
Total current liabilities |  | $ | 147,329 |  |  | $ | 1,281 |  |  | $ | 148,610 |
Deferred tax liability |  | $ | 3,042 |  |  | $ | 11,175 |  |  | $ | 14,217 |
Total non-current liabilities |  | $ | 247,881 |  |  | $ | 11,175 |  |  | $ | 259,056 |
Total liabilities |  | $ | 395,210 |  |  | $ | 12,456 |  |  | $ | 407,666 |
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation ("APC") |  | $ | 13,682 |  |  | $ | 555 |  |  | $ | 14,237 |
Retained earnings |  | $ | 192,678 |  |  | $ | (10,261) |  |  | $ | 182,417 |
Non-controlling interest |  | $ | 2,191 |  |  | $ | (442) |  |  | $ | 1,749 |
Total stockholders' equity |  | $ | 555,013 |  |  | $ | (10,703) |  |  | $ | 544,310 |
|  | Three months ended March 31, 2022 |  | Adjustments |  | Three months ended March 31, 2022 |  |
|  | As previously reported |  |  | As restated |
CONSOLIDATED STATEMENTS OF INCOME |  |
Provision for income taxes |  | $ | 6,195 |  |  | $ | 623 |  |  | $ | 6,818 |  |  |
Net income |  | $ | 12,073 |  |  | $ | (623) |  |  | $ | 11,450 |  |  |
Net income attributable to noncontrolling interests |  | $ | (2,191) |  |  | $ | (123) |  |  | $ | (2,314) |  |  |
Net income attributable to Apollo Medical Holdings, Inc. |  | $ | 14,264 |  |  | $ | (500) |  |  | $ | 13,764 |  |  |
Earnings per share – basic |  | $ | 0.32 |  |  | $ | (0.01) |  |  | $ | 0.31 |  |  |
Earnings per share – diluted |  | $ | 0.31 |  |  | $ | (0.01) |  |  | $ | 0.30 |  |  |
|  | March 31, 2022 |  | Adjustments |  | March 31, 2022 |  |
|  | As previously reported |  |  | As restated |
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY |  |
Mezzanine Equity – Non-controlling Interest in APC - Net loss |  | $ | (3,129) |  |  | $ | (123) |  |  | $ | (3,252) |  |  |
Retained Earnings (Accumulated Deficit) - Net income |  | $ | 14,264 |  |  | $ | (500) |  |  | $ | 13,764 |  |  |
Mezzanine Equity – Non-controlling Interest in APC |  | $ | 52,151 |  |  | $ | 902 |  |  | $ | 53,053 |  |  |
Retained Earnings (Accumulated Deficit) |  | $ | 157,893 |  |  | $ | (6,883) |  |  | $ | 151,010 |  |  |
Non-controlling interest |  |  |  |  |  |  |  |
Stockholders’ Equity |  | $ | 479,521 |  |  | $ | (6,883) |  |  | $ | 472,638 |  |  |
|  | Three months ended March 31, 2022 |  | Adjustments |  | Three months ended March 31, 2022 |  |
|  | As previously reported |  |  | As restated |
CONSOLIDATED STATEMENTS OF CASH FLOWS |  |
Net income |  | $ | 12,073 |  |  | $ | (623) |  |  | $ | 11,450 |  |  |
Deferred tax |  | $ | 1,985 |  |  | $ | 194 |  |  | $ | 2,179 |  |  |
Income taxes payable/receivable |  | $ | 4,241 |  |  | $ | 430 |  |  | $ | 4,671 |  |  |

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration